Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

BUY
$107.32 - $113.5 $3,648 - $3,859
34 Added 0.33%
10,371 $1.13 Million
Q4 2022

Feb 13, 2023

SELL
$62.39 - $113.8 $46,792 - $85,350
-750 Reduced 6.76%
10,337 $1.18 Million
Q4 2021

Feb 10, 2022

SELL
$98.56 - $119.91 $128,325 - $156,122
-1,302 Reduced 10.51%
11,087 $1.2 Million
Q2 2021

Aug 11, 2021

SELL
$86.24 - $95.92 $67,094 - $74,625
-778 Reduced 5.91%
12,389 $1.16 Million
Q1 2021

May 12, 2021

SELL
$71.83 - $95.48 $519,330 - $690,320
-7,230 Reduced 35.45%
13,167 $1.21 Million
Q4 2020

Feb 10, 2021

SELL
$67.0 - $84.39 $105,726 - $133,167
-1,578 Reduced 7.18%
20,397 $1.49 Million
Q3 2020

Nov 13, 2020

SELL
$55.23 - $79.93 $2.67 Million - $3.86 Million
-48,346 Reduced 68.75%
21,975 $1.71 Million
Q2 2020

Aug 12, 2020

SELL
$30.2 - $56.98 $1.36 Million - $2.56 Million
-45,005 Reduced 39.02%
70,321 $3.91 Million
Q1 2020

May 14, 2020

SELL
$24.87 - $38.56 $6.54 Million - $10.1 Million
-263,009 Reduced 69.52%
115,326 $3.42 Million
Q4 2019

Feb 12, 2020

SELL
$25.43 - $36.67 $1.14 Million - $1.64 Million
-44,723 Reduced 10.57%
378,335 $13.7 Million
Q3 2019

Nov 12, 2019

SELL
$23.0 - $27.97 $17.4 Million - $21.2 Million
-758,093 Reduced 64.18%
423,058 $11.5 Million
Q2 2019

Aug 09, 2019

SELL
$22.81 - $28.48 $5.83 Million - $7.27 Million
-255,433 Reduced 17.78%
1,181,151 $28.4 Million
Q1 2019

May 15, 2019

BUY
$19.49 - $29.01 $28 Million - $41.7 Million
1,436,584 New
1,436,584 $38 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.